Biotech

Northwell experts update brain cancer biotechnology

By GREGORY ZELLER // A Northwell Health inner circle with deep biotechnology roots has issued a “comprehensive update” of breakthroughs in brain tumor research. The roadmap of next-generation advances in the difficult war against brain cancers comes from physicians at New York City’s Lenox Hill Hospital, by way of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Feinstein Institutes for Medical Research, famed bioscience hub. The team on Thursday announced a…

Read More

Codagenix scores big with $20M Series B round

By GREGORY ZELLER // A stellar $20 million investment round has blasted a Long Island biotech into the stratosphere, and a new tax bracket. Farmingdale-based Codagenix Inc., a 2012 startup launched by Stony Brook University assistant research professor Steffan Mueller and Farmingdale State College biology professor J. Robert Coleman, has closed a $20 million Series B investment round, led by Adjuvant Capital, a New York City/San Francisco venture capital firm focused on life sciences. Also…


In TD grant, big win for CSHL, Tuveson and society

By GREGORY ZELLER // A cutting-edge Cold Spring Harbor Laboratory cancer-detection science will get cutting-edgier, thanks to a stocking stuffer from TD Bank. New Jersey-based TD announced Tuesday more than $3 million in fresh grants, comprising the second funding round of its TD Ready Challenge, an application-based national competition designed to balance social scales while innovating early disease detection and intervention. Among them: a $750,000 award for CSHL aimed at advancing organoid-based clinical tests –…


Pending patent a cellulosic score for Applied DNA

By GREGORY ZELLER // A Stony Brook-based biotech on the leading edge of DNA-based product authentication is about to add another U.S. patent to its growing collection. Applied DNA Sciences, which has raced to the front of the Polymerase Chain Reaction-based forensic-traceability field, has received a Notice of Allowance from the U.S. Patent and Trademark Office for its “Methods of Marking Cellulosic Products” – meaning its application to patent the technique has been allowed, and…


‘Linear DNA’ combo shows punch in cancer fight

By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent its unique DNA-sequencing technology to two vaccine-candidate tests run by Italian R&D company Takis Biotech, which is hot on the trail of new therapeutic cancer vaccines. It might be catching up. On Thursday, LineaRX announced that both vaccines – each produced in “linear DNA” form…


Down is up at Applied DNA, with the good stuff

By GREGORY ZELLER // An aggressive Long Island biotech is getting down, literally, with another global textiles supplier. Stony Brook-based supply-chain security specialist Applied DNA Sciences announced Thursday a new sales and marketing partnership with Navarpluma, a premier supplier of down and feathers to worldwide textiles manufacturers. Financial terms of the deal were not disclosed, but this latest collaboration with an international partner will see Applied DNA’s SigNature DNA molecular-tracking system applied to Navarpluma’s products, which…


Mapping scattered pictures, in the corners of our mind

By GREGORY ZELLER // Straight from the hippocampus (and the horse’s mouth) comes a new research paper in the journal Science, highlighting landmark innovations in human brain mapping. Published Aug. 16 by the peer-reviewed academic journal of the American Association for the Advancement of Science, “Hippocampal Sharp-Wave Ripples Linked to Visual Episodic Recollection in Humans” carries a heavy title but a simple synopsis: real-time mapping of specific brain neurons that fire when humans form visual…